CVS250117P50000
- 0.44
- -0.08-15.38%
CVS Health Newsroom
Bernstein Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $52
Bernstein Sticks to Their Hold Rating for CVS Health (CVS)
Argus Adjusts Price Target on CVS Health to $68 From $75
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $60
Evercore ISI Reaffirms Their Buy Rating on CVS Health (CVS)
TD Cowen Downgrades CVS Health(CVS.US) to Hold Rating, Maintains Target Price $80
TD Cowen Remains a Hold on CVS Health (CVS)
BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $63
Truist Financial Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $60
CVS Health Is Maintained at Buy by Truist Securities
CVS Health Analyst Ratings
Rice downgraded CVS Health's target price to $58.
Mizuho Securities Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $58
Mizuho Adjusts Price Target on CVS Health to $58 From $66, Keeps Outperform Rating
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $80
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Prothena (PRTA) and CVS Health (CVS)
CVS Health: Strategic Buy Rating Amidst Industry Reforms and Valuation Opportunities
Baird Adjusts CVS Health Price Target to $51 From $61, Maintains Neutral Rating
Wells Fargo Trim Price Target on CVS Health to $65 From $66
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $51